2552. Arboviruses in Transplantation
Session: Symposium: When Transplant Tours the World
Saturday, October 6, 2018: 2:50 PM
Room: N 25
Michele I Morris, MD, FIDSA, FAST, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL

Dr. Michele I. Morris is a Professor of Clinical Medicine in the Division of Infectious Diseases at the University of Miami Miller School of Medicine in Miami, Florida. She is Director of the Immunocompromised Host Section, providing consultation services to hematology/oncology patients and solid organ and stem cell transplant recipients at Jackson Memorial Hospital, University of Miami Hospital, and Sylvester Cancer Center. She participates in oversight and policy development at a medical center that performs over 750 solid organ and stem cell transplants annually. She is a Fellow of the American Society of Transplantation and the Infectious Diseases Society of America. She is past president of the international Transplantation Society Transplant Infectious Diseases section. She is a member of the Mycoses Study Group, and has been an executive board member in the American Society of Transplantation ID-Community of Practice. She has also been active in the Education Committee of the ID-COP, and actively participated in the ID-COP’s Influenza and Chagas Disease working groups. She served on the United Network for Organ Sharing Disease Transmission Advisory Committee. She has published over 65 papers and 5 book chapters. In addition to being an active academic clinician, she has been the principal investigator in over 25 clinical trials. Her clinical research focuses on the diagnosis and management of invasive fungal and mycobacterial infections and the prevention and treatment of transplant-related infectious diseases, with a focus on transplantation in the tropics.


M. I. Morris, Chimerix: Investigator and Scientific Advisor , Consulting fee and Research support . Merck: Investigator , Research grant .

See more of: When Transplant Tours the World
See more of: Symposium
<< Previous Presentation | Next Presentation

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.